Patents by Inventor Kentarou Doi

Kentarou Doi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for insulin resistance improving and a method for prevention or treatment of diabetes
    Patent number: 8916521
    Abstract: A new compound inhibiting phosphorylation of Ser727 of STAT3, a phosphorylation inhibitor containing the new compound, an insulin resistance improving agent and a preventive or therapeutic agent for diabetes; and a screening method for at least one of the insulin resistance improving agent and the preventive or therapeutic agent for diabetes.
    Type: Grant
    Filed: March 16, 2012
    Date of Patent: December 23, 2014
    Assignee: Fujitsu Limited
    Inventors: Kentarou Doi, Takayoshi Kinoshita, Atsushi Tomonaga, Hajime Sugiyama, Matsuyo Wada
  • Screening method for an insulin resistance improving agent or a therapeutic agent for diabetes
    Patent number: 8492105
    Abstract: A new compound inhibiting phosphorylation of Ser727 of STAT3, a phosphorylation inhibitor containing the new compound, an insulin resistance improving agent and a preventive or therapeutic agent for diabetes; and a screening method for at least one of the insulin resistance improving agent and the preventive or therapeutic agent for diabetes.
    Type: Grant
    Filed: September 14, 2012
    Date of Patent: July 23, 2013
    Assignee: Fujitsu Limited
    Inventors: Kentarou Doi, Takayoshi Kinoshita, Atsushi Tomonaga, Hajime Sugiyama, Matsuyo Wada
  • COMPOUND, PHOSPHORYLATION INHIBITOR, INSULIN RESISTANCE IMPROVING AGENT, PREVENTIVE OR THERAPEUTIC AGENT FOR DIABETES, AND SCREENING METHOD
    Publication number: 20130022993
    Abstract: A new compound inhibiting phosphorylation of Ser727 of STAT3, a phosphorylation inhibitor containing the new compound, an insulin resistance improving agent and a preventive or therapeutic agent for diabetes; and a screening method for at least one of the insulin resistance improving agent and the preventive or therapeutic agent for diabetes.
    Type: Application
    Filed: September 14, 2012
    Publication date: January 24, 2013
    Applicant: FUJITSU LIMITED
    Inventors: Kentarou Doi, Takayoshi Kinoshita, Atsushi Tomonaga, Hajime Sugiyama, Mutsuyo Wada
  • Compounds having an isolated peptide consisting of structure (I)
    Patent number: 8354373
    Abstract: A new compound inhibiting phosphorylation of Ser727 of STAT3, a phosphorylation inhibitor containing the new compound, an insulin resistance improving agent and a preventive or therapeutic agent for diabetes; and a screening method for at least one of the insulin resistance improving agent and the preventive or therapeutic agent for diabetes.
    Type: Grant
    Filed: August 22, 2011
    Date of Patent: January 15, 2013
    Assignee: Fujitsu Limited
    Inventors: Kentarou Doi, Takayoshi Kinoshita, Atsushi Tomonaga, Hajime Sugiyama, Mutsuyo Wada
  • Computer product, analysis support apparatus, and analysis support method
    Patent number: 8244480
    Abstract: A non-transitory computer-readable recording medium stores therein an analysis support program causing a computer to execute receiving test result data identifying an analysis subject molecule, and quantity-changing molecules that have changed in quantity due to administration or deficiency of the analysis subject molecule in a test subject; acquiring a first pathway indicating an interaction between the quantity-changing molecules identified by the test result data and a second pathway indicating a molecular interaction with the analysis subject molecule, from a database storing therein for each molecular interaction, a type; determining from among biological phenomena correlated with the interaction between quantity-changing molecules of the first pathway, determines a biological phenomenon other than a biological phenomenon correlated with a molecular interaction of the second pathway to be a novel biological phenomenon caused by administration or deficiency of the analysis subject molecule; and outputting
    Type: Grant
    Filed: March 31, 2010
    Date of Patent: August 14, 2012
    Assignee: Fujitsu Limited
    Inventor: Kentarou Doi
  • COMPOUND, PHOSPHORYLATION INHIBITOR, INSULIN RESISTANCE IMPROVING AGENT, PREVENTIVE OR THERAPEUTIC AGENT FOR DIABETES, AND SCREENING METHOD
    Publication number: 20120202969
    Abstract: A new compound inhibiting phosphorylation of Ser727 of STAT3, a phosphorylation inhibitor containing the new compound, an insulin resistance improving agent and a preventive or therapeutic agent for diabetes; and a screening method for at least one of the insulin resistance improving agent and the preventive or therapeutic agent for diabetes.
    Type: Application
    Filed: March 16, 2012
    Publication date: August 9, 2012
    Applicant: FUJITSU LIMITED
    Inventors: Kentarou Doi, Takayoshi Kinoshita, Atsushi Tomonaga, Hajime Sugiyama, Matsuyo Wada
  • NEW COMPOUND, PHOSPHORYLATION INHIBITOR, INSULIN RESISTANCE IMPROVING AGENT, PREVENTIVE OR THERAPEUTIC AGENT FOR DIABETES, AND SCREENING METHOD
    Publication number: 20110318753
    Abstract: A new compound inhibiting phosphorylation of Ser727 of STAT3, a phosphorylation inhibitor containing the new compound, an insulin resistance improving agent and a preventive or therapeutic agent for diabetes; and a screening method for at least one of the insulin resistance improving agent and the preventive or therapeutic agent for diabetes.
    Type: Application
    Filed: August 22, 2011
    Publication date: December 29, 2011
    Applicant: FUJITSU LIMITED
    Inventors: Kentarou Doi, Takayoshi Kinoshita, Atsushi Tomonaga, Hajime Sugiyama, Mutsuyo Wada
  • COMPUTER PRODUCT, ANALYSIS SUPPORT APPARATUS, AND ANALYSIS SUPPORT METHOD
    Publication number: 20100185400
    Abstract: A non-transitory computer-readable recording medium stores therein an analysis support program causing a computer to execute receiving test result data identifying an analysis subject molecule, and quantity-changing molecules that have changed in quantity due to administration or deficiency of the analysis subject molecule in a test subject; acquiring a first pathway indicating an interaction between the quantity-changing molecules identified by the test result data and a second pathway indicating a molecular interaction with the analysis subject molecule, from a database storing therein for each molecular interaction, a type; determining from among biological phenomena correlated with the interaction between quantity-changing molecules of the first pathway, determines a biological phenomenon other than a biological phenomenon correlated with a molecular interaction of the second pathway to be a novel biological phenomenon caused by administration or deficiency of the analysis subject molecule; and outputting
    Type: Application
    Filed: March 31, 2010
    Publication date: July 22, 2010
    Applicant: FUJITSU LIMITED
    Inventor: Kentarou DOI